ScholarIQanswers from OpenAlex & ORCID
Augusto Vaglio
ResearcherPublications, citations & collaboration network
Augusto Vaglio is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Augusto Vaglio have?
ScholarIQindexed works
Augusto Vaglio has 15 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Augusto Vaglio have?
ScholarIQcitation count
Augusto Vaglio has 50 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Augusto Vaglio?
ScholarIQh-index
Augusto Vaglio has an h-index of 4 in OpenAlex.
What is the i10-index of Augusto Vaglio?
ScholarIQi10-index
Augusto Vaglio has an i10-index of 1 in OpenAlex.
What is the OpenAlex record for Augusto Vaglio?
ScholarIQopenalex
The OpenAlex for Augusto Vaglio is on the source record.
What are the most-cited papers on Augusto Vaglio?
ScholarIQmost cited works
Long-term outcome and prognosis of mixed histiocytosis (Erdheim-Chester disease and Langerhans Cell Histiocytosis)
Francesco Pegoraro, Matthias Papo, Fleur Cohen‐Aubart, Francesco Peyronel, Gianmarco Lugli, Irene Trambusti, G. Baulier, Mathilde de Menthon, Tanguy Le Scornet, E. Oziol, Nicole Ferreira-Maldent, Olivier Hermine, Benoit Faucher, Dirk Koschel, Nicole Straetmans, Noémie Abisror, Benjamin Terrier, François Lifermann, Jérôme Razanamahery, Yves Allenbach, Jeremy Keraen, Sophie Bulifon, B. Hervier, Annamaria Buccoliero, Frédéric Charlotte, Quentin Monzani, Samia Boussouar, Natalia Shor, Annalisa Tondo, Stéphane Barète, Ahmed Idbaïh, Abdellatif Tazi, Elena Sieni, Zahir Amoura, Jean‐François Emile, Augusto Vaglio, Julien Haroche
Treatment holidays in patients with Erdheim-Chester disease receiving vemurafenib: a prospective pilot study
Francesco Pegoraro, Francesco Catamerò, Federica Allegretta, Giulia Palazzini, Francesco Peyronel, Eli L. Diamond, Augusto Vaglio
MEK inhibitors are effective in Erdheim–Chester disease regardless of MAPK pathway mutations
Francesco Pegoraro, Fleur Cohen-Aubart, Matthias Papo, Francesco Catamerò, Jérôme Razanamahery, Zahir Amoura, Jean‐François Emile, Augusto Vaglio, Julien Haroche
New Treatment Regimens, New Drugs, and New Treatment Goals for Lupus Nephritis
Giovanni Maria Rossi, Augusto Vaglio
Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease
Corrado Campochiaro, Alessandro Tomelleri, Francesco Catamerò, Francesco Pegoraro, Augusto Vaglio, Lorenzo Dagna